Claritev Corp (NYSE:CTEV)
$ 30.49 +0.43 (+1.43%) Market Cap: 519.79 Mil Enterprise Value: 5.24 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

Claritev Corp at JPMorgan Healthcare Conference Transcript

Jan 15, 2026 / 03:30PM GMT
Release Date Price: $30.06 (-1.35%)
Unidentified Participant

All right, thank you everyone for joining us this morning. My name is [Harry Pearson]. I'm with JP Morgan's Healthcare Investment banking team. It's my pleasure to introduce Travis Dalton, President and CEO, and Doug Garis, CFO of Claritev. We're going to have a presentation followed up by a little bit of Q&A. Travis, you want to take it.

Travis Dalton
Claritev Corp - Chairman of the Board, President, Chief Executive Officer

Yeah, thanks, Harry. Appreciate it. Good morning, everybody. Thanks for your time. Thanks for being here. As noted, I'm Travis, I'm the CEO. I joined in March of 24, and then Doug Garis, our CFO. So thanks for having us. Okay, so I'm going to take a walk through the park of the artist formerly known as Multiplan, now Claritev.

And so, what I'll do is take you through a little bit of our vision some of our product set, how we've been thinking about the transformation of the company. And where we're going. So look, purpose statements can become pithy. Oh wow, you guys are about transparency. This is what we do

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot